Crossmark

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Crossref DOI link: https://doi.org/10.1038/s41379-021-00922-7

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chiang, Sarah

Vasudevaraja, Varshini

Serrano, Jonathan

Stewart, Colin J.R.

Oliva, Esther

Momeni-Boroujeni, Amir https://orcid.org/0000-0002-7714-370X
Jungbluth, Achim A.

Da Cruz Paula, Arnaud

da Silva, Edaise M. https://orcid.org/0000-0003-3281-7333
Weigelt, Britta https://orcid.org/0000-0001-9927-1270
Park, Kay J. https://orcid.org/0000-0001-8989-2938
Soslow, Robert A. https://orcid.org/0000-0002-7269-5898
Murali, Rajmohan https://orcid.org/0000-0001-6988-4295
Ellenson, Lora H. https://orcid.org/0000-0001-9127-6982
Benayed, Ryma

Ladanyi, Marc

Abu-Rustum, Nadeem R.

Dickson, Mark A.

Cohen, Seth

Aghajanian, Carol

Hensley, Martee L.

Lee, Cheng-Han https://orcid.org/0000-0003-2094-1222
Snuderl, Matija

Konner, Jason A.
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Cancer Institute
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-021-00922-7

Content Type: article

Copyright: © 2021 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below